A review of the S100 proteins in cancer
Top Cited Papers
- 30 April 2008
- journal article
- review article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 34 (4), 357-364
- https://doi.org/10.1016/j.ejso.2007.04.009
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- S100 chemokines mediate bookmarking of premetastatic nichesNature, 2006
- Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasisNature, 2006
- S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9Proceedings of the National Academy of Sciences of the United States of America, 2006
- Calcium-dependent and -independent interactions of the S100 protein familyBiochemical Journal, 2006
- S100A8 and S100A9 activate MAP kinase and NF-κB signaling pathways and trigger translocation of RAGE in human prostate cancer cellsExperimental Cell Research, 2006
- Normal values of serum S-100B predict prolonged survival for stage IV melanoma patientsEuropean Journal of Cancer, 2005
- S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiationEuropean Journal of Cancer, 2004
- Mts1 Regulates the Assembly of Nonmuscle Myosin-IIABiochemistry, 2003
- Differential expression of the Ca2+ binding S100A6 protein in normal, preneoplastic and neoplastic colon mucosaEuropean Journal of Cancer, 2000
- Clinical significance of serum S100 in metastatic malignant melanomaEuropean Journal of Cancer, 1995